Summary of significant accounting policies (Details Narrative) - USD ($) |
3 Months Ended | 5 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|---|
Sep. 30, 2015 |
Sep. 30, 2014 |
Sep. 30, 2014 |
Sep. 30, 2015 |
Mar. 31, 2015 |
May. 11, 2014 |
|
Grant income | $ 29,999 | |||||
Cash and cash equivalents | $ 3,414,421 | $ 272,925 | $ 272,925 | $ 3,414,421 | $ 687,739 | |
Shares outstanding | 12,392,115 | 12,392,115 | 5,493,200 | |||
Restricted Stock [Member] | ||||||
Shares outstanding | 623,855 | 623,855 | 623,855 | 623,855 | ||
National Science Foundation [Member] | ||||||
Awarded grants | $ 29,999 | |||||
Grant income | $ 29,999 |
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|